Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Sindelfingen

6 clinical trials in Sindelfingen, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Sindelfingen at a glance
6
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

6 trials in Sindelfingen

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:University Of Cologne
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:WSG Women's Cancer Study Group GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ribociclib
  • Sponsor:WSG Women's Cancer Study Group GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bleomycin Sulfate
  • Sponsor:University Of Cologne
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Universitaet Leipzig
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cytarabine
  • Sponsor:Universitaet Leipzig

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Sindelfingen

What the registry says about research in the country

01 Lymphoma Research

Innovative research focusing on Advanced Stage Hodgkin Lymphoma, evaluating new treatment combinations to reduce toxicity while maintaining therapeutic effectiveness.

  • Treatment-related morbidity assessment
  • Progression-free survival studies
  • Radiotherapy optimization

Novel therapeutic approaches combining established protocols with targeted interventions.

02 Chronic Lymphocytic Leukemia Studies

Advanced research targeting high-risk CLL patients, investigating triple-combination therapies for improved treatment outcomes.

  • Genetic mutation analysis
  • Novel drug combinations
  • Treatment resistance studies

Focusing on personalized treatment approaches for patients with specific genetic markers.

03 Acute Myeloid Leukemia Research

Comprehensive studies on Acute Myeloid Leukemia and high-risk myelodysplastic neoplasia, exploring innovative treatment combinations.

  • Intensive chemotherapy protocols
  • Stem cell transplantation research
  • Alternative treatment strategies

Investigating new therapeutic options for patients ineligible for standard treatments.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.